Atovaquone-proguanil 250-100 100S
Ended Awarded
- Contract number
- SPE2DB26FXSGZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,479
Award facts
- Contract value 100% obligated
- $8,479.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,479.30 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 in quantities of 100 units. The contract, awarded on November 12, 2025, with an ultimate completion date of November 13, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will be executed from the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor specializing in pharmaceutical products and medical supplies for military and veteran healthcare systems. The Atovaquone-Proguanil antimalarial medication supplied under this order supports the broad medical supply needs of the Defense Health Agency and other government healthcare entities. As a prime vendor under the DLA Troop Support Medical IDC, the company maintains capability to supply a comprehensive range of pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs globally, with anticipated expansion through the planned Pharmaceutical Prime Vendor Global Program Generation V regional contracts.
Quick answers
Who was awarded contract SPE2DB26FXSGZ?
SPE2DB26FXSGZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FXSGZ worth?
The government has obligated $8,479 on SPE2DB26FXSGZ.
Is contract SPE2DB26FXSGZ an order under another contract?
Yes. SPE2DB26FXSGZ is a delivery order under SPE2DB25D7060, an indefinite delivery contract.
Was contract SPE2DB26FXSGZ competed?
The extent of competition for SPE2DB26FXSGZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award